GLOW Research Peptide Blend

GLOW is not a single chemical entity. It is a defined mixture of three separately synthesised research peptides, combined at stated amounts and freeze-dried together in one vial. Each component retains its own chemical identity, its own molecular data and its own analytical profile.

That has a direct consequence for documentation: there is no single meaningful purity figure for a blend. A report that characterises GLOW reports each component separately against its own label claim, which is why the analytical documentation for this formulation is presented as a component table rather than one number.

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys), CAS 89030-95-5. It is the largest component of the formulation by mass at 50 mg.

BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, molecular formula C62H98N16O22, CAS 137525-51-0, present at 10 mg.

TB-500 is supplied under a research designation that is applied to either full-length thymosin β4 or its actin-binding fragment Ac-LKKTETQ depending on the supplier; it is present at 10 mg. The analytical report issued for a given batch states which analyte was characterised.

Each component is resolved chromatographically by HPLC-DAD and reported as an individual area-percent purity value alongside the measured content against its stated label claim. Identity for each component is reported as conforming by retention-time and UV/DAD comparison against a reference standard; current reports do not include mass-spectrometry results.

Because the components differ substantially in size and polarity, resolving all three in one run is a method-development exercise in its own right; a report should therefore state the method used, not only the results.

A Certificate of Analysis links a submitted sample to the analytical work performed on it. Current Vial Drop Labs reports are produced by validated HPLC-DAD methodology and answer two separate questions — what the material is, and how much of it is present.

Vial Drop Labs publishes independent analytical reports for tested research materials, with available reports accessible through the Research Documentation portal against the research material and the sample identified on each report. Each analytical report applies only to the sample submitted for analysis and should not be interpreted as testing of every vial or production unit.

Not every report is publicly listed. Where no report has been published for a material, the portal shows none rather than substituting another material's, strength's or batch's results. Documentation is never averaged, combined, or extrapolated between lots.

Current reports are issued by an independent third-party analytical laboratory using validated HPLC-DAD methodology. They report chromatographic purity as area %, content per vial against label claim, and identity as conforming by retention-time and UV/DAD comparison against a reference standard. Current reports do not include mass-spectrometry results.

Vial Drop Labs makes no representation that material is pharmaceutical grade, clinical grade, sterile, safe, or approved by any regulatory authority. Published documentation states exactly what was tested, by which method, and on which date — nothing further should be inferred from it.

Material is supplied lyophilised in a sealed glass vial. General laboratory practice for lyophilised peptides applies: store sealed at -20 °C for long-term storage, protect from light, and minimise exposure to atmospheric moisture.

Allow a cold sealed vial to equilibrate to ambient temperature before opening so that atmospheric moisture does not condense onto the dry cake. Lyophilised peptide material is hygroscopic, and repeated warm/cold cycling of an opened vial is the most common cause of avoidable degradation in a laboratory setting.

Handle as an uncharacterised laboratory chemical using standard laboratory protective equipment and institutional handling procedures.

This material is supplied strictly as a laboratory research chemical. It is not a drug, supplement, cosmetic, food or medical device, and it is not manufactured, labelled or sold for human or animal use of any kind.

Vial Drop Labs does not provide, and cannot provide, dosing, administration, preparation-for-use, therapeutic or clinical guidance. Published information is limited to chemical identity, laboratory handling and analytical documentation.